filmov
tv
Borderline Resectable Pancreatic Cancer | Dr Vinay Samuel Gaikwad (GI & HPB Surgical Oncologist)
Показать описание
Borderline resectable pancreatic cancer (BRPC) comprises 10% to 20% of the total patient population and is defined by three distinct dimensions: anatomic, biologic, and conditional. Specific use of neoadjuvant therapies and performance of high-quality surgery in high-volume centers offers the best-possible treatment for BRPC.
Dr. Vinay Samuel Gaikwad (Director -Surgical Oncology @ CK Birla Hospital) is a profound doctor with vast experience of more than 14 years in the field of Surgical Oncology and has been trained from Tata Memorial Hospital, Mumbai & MSKCC, New York, currently associated with Paras Cancer Centre-Paras Hospital - Gurgaon, India. He has an expertise in highly specialized Minimally Invasive Cancer Surgeries such as surgeries of the Colon, Rectum, Stomach, Esophagus, Pancreas, Liver & Gall Bladder. He also performs most advanced cancer surgeries like #HIPEC & #PIPAC procedures and has operated more than 50 such cases till now. Dr. Gaikwad continually strives to deliver superior outcomes while remaining patient-centered.
Contact/Appointment @ +91 99109 76320 / +91 95996 45743
Dr. Vinay Samuel Gaikwad (Director -Surgical Oncology @ CK Birla Hospital) is a profound doctor with vast experience of more than 14 years in the field of Surgical Oncology and has been trained from Tata Memorial Hospital, Mumbai & MSKCC, New York, currently associated with Paras Cancer Centre-Paras Hospital - Gurgaon, India. He has an expertise in highly specialized Minimally Invasive Cancer Surgeries such as surgeries of the Colon, Rectum, Stomach, Esophagus, Pancreas, Liver & Gall Bladder. He also performs most advanced cancer surgeries like #HIPEC & #PIPAC procedures and has operated more than 50 such cases till now. Dr. Gaikwad continually strives to deliver superior outcomes while remaining patient-centered.
Contact/Appointment @ +91 99109 76320 / +91 95996 45743
Borderline Resectable Pancreatic Cancer
Debate: How to treat borderline, resectable pancreatic cancer? - Chemotherapy alone
Analyzing the ESPAC-5F Trial in Borderline Resectable Pancreatic Cancer
Diagnosed with locally advanced, borderline resectable or stage 3 pancreatic cancer. What this means
Management of Borderline Resectable Pancreas Cancer
Approaches to Borderline Resectable/Locally Advanced
Borderline Resectable Pancreatic Cancer
Debate: Pre-Op Treatment of Borderline Resectable Pancreatic Cancer - SBRT
Debate: Pre-Op Treatment of Borderline Resectable Pancreatic Cancer - Conventional RT
Borderline Resectable Pancreatic Cancer | Dr Vinay Samuel Gaikwad (GI & HPB Surgical Oncologist...
My Journey: Treatment and Recovery for Borderline Resectable Pancreatic Cancer
Dr. Ribeiro on Criteria for Determining Borderline Resectability in Pancreatic Cancer
Staging Pancreatic Cancer - case 2 - Borderline resectable
Resectable Pancreatic Cancer Debate: Total Neoadjuvant vs Adjuvant Therapy - Total Neoadjuvant
Role of Chemoradiation in Resectable Pancreatic Cancer
Session 7: Borderline Resectable Pancreatic Cancer - Discussion
Staging for Pancreatic Cancer
Controversy Debate 1: Is it justified to move from adjuvant to neo-adjuvant treatment? - Yes
2021 West Oncology | Gastrointestinal Cancers | Surgical Perspective on Pancreatic Cancer
Treatment Options for Resectable, Borderline by Daniel H. Ahn, D.O.| Preview
Borderline Resectable and Locally Advanced Pancreas Cancer
ICAHO20 - ASCO Direct™ Highlights - Dr. Andrew Coveler - Pancreatic Cancer
Part 1: Borderline resectable pancreatic ductal adenocarcinoma. J. Izbicki
Pancreatic Cancer Resectability Project
Комментарии